Eskiler, Guney G.Bezdegumeli, E.Ozman, ZeynepOzkan, Deveci A.Bilir, C.Kucukakca, B. N.Ince, M. N.Men, A. Y.Aktas, O.Horoz, Y. E.Akpinar, D.Genc, IKaleli, S.2020-10-222020-10-222019-01-01Eskiler G. G. , Bezdegumeli E., Ozman Z., Ozkan D. A. , Bilir C., Kucukakca B. N. , Ince M. N. , Men A. Y. , Aktas O., Horoz Y. E. , et al., -IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia-, BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.120, ss.819-826, 2019http://hdl.handle.net/20.500.12645/24149OBJECTIVES: We investigated the changes in the IL-6 and STAT3 expression levels in cachectic and non-cachectic patients with gastric, lung and breast cancer and evaluated the association between IL-6 and STAT3 levels and cancer types in terms of cachexia condition. BACKGROUND: Cancer-associated cachexia, observed in nearly 50.80 % of cancer patients, has drawn attention in advanced patients. IL-6/JAK/STAT pathway plays an essential role in the progression of cancer cachexia through the regulation of the inflammatory response.ArticleWOS:0004979715000038507581485710.4149/bll_2019_136